Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Vessel-sparing surgery for hip replacement

Official title: Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

Run by Ziekenhuis Oost-Limburg · NCT06308965 · Data updated 2026-11-12

This study is testing a new hip replacement surgery that aims to save blood vessels to see if it helps patients recover better than the traditional method that cuts them.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorZiekenhuis Oost-Limburg
Academic / other
Locations1 site (Genk, Limburg)
StatusRecruiting
StartedJune 11, 2024
Main results expectedMarch 2025
Study endsMarch 2027
Registry record updatedNovember 15, 2024
Trial IDNCT06308965 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 scheduled for total hip arthroplasty by the specified surgeons.

Probably not a fit

Patients with neurological disorders, previous hip surgeries, or significant hip deformities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the feasibility and outcomes of a vessel-sparing surgical technique during direct anterior approach total hip arthroplasty (THA). The study compares patients undergoing vessel-sparing surgery with those who have their vessels ligated, focusing on the incidence of tensor fascia lata (TFL) tendinopathy and patient-reported outcomes. It is a monocentric, prospective, randomized, and blinded trial aiming to enroll 100 patients over a minimum of three years. The hypothesis is that preserving blood vessels will lead to better clinical outcomes.

Why it matters

Potential benefit: If successful, this approach could reduce the incidence of TFL tendinopathy and improve recovery outcomes for patients undergoing hip replacement.

How similar studies have gone: While this approach is novel, similar studies have shown promising results in preserving blood vessels during surgical procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria To be eligible to participate in this study, a subject must meet all criteria below;

* Scheduled for THA by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten
* Provide signed and dated informed consent
* Males or females age \> 18 years

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

* Neurological problems with sensorial and/or motoric disturbances (Multiple Sclerosis, Parkinson's disease, hemiplegia, …)
* Previous surgery of the ipsilateral hip
* Ipsilateral neck of femur fracture
* Previous contralateral THA
* Significant hip deformity: Crowe type 3 and 4 dysplasia, Leg-Calvé-Perthes
* Avascular necrosis of the femoral head
* Participating in another study that may interfere with participation in this study

Where it's running

  • Ziekenhuis Oost-Limburg
    Genk, Limburg, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.